The novel therapy of this peptide represents a exciting advance in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide700618.blog-a-story.com/23893445/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment